Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Study on the effect of pentachlorophenol on the succinate oxidase activity of submitochondrial particles and on the reduction level of cytochromes b revealed that the Ki value for
PCP
is equal to 2-4 microM. The succinate-DCPIP-reductase activity is noncompetitively inhibited with
PCP
(by 75-85%) (Ki = 3.6 microM). In the case of the succinate-
PMS
-reductase activity
PCP
at micromolar concentrations decreases the value of V only by 40% (C50 = 2 microM) with a simultaneous increase of the Km value for
PMS
. The identity of Ki values for
PCP
under these conditions suggests that the effect of
PCP
is due to the inhibitor interaction with the same component of the succinate dehydrogenase complex. The type of action of
PCP
on the succinate-acceptor-reductase activities indicates that the inhibiting effect of
PCP
on succinate oxidations is similar to that exerted by traditional inhibitors of succinate dehydrogenase--tenoyltrifluoroacetone and carboxins. Since
PCP
inhibits succinate dehydrogenase at low concentrations, it seems likely that the biological (pesticidal) effect of
PCP
is provided for not only by its uncoupling action but also by the inhibition of succinate oxidation in the respiratory chain.
...
PMID:[Pentachlorophenol inhibition of succinate oxidation by the respiratory chain in submitochondrial particles from the bovine heart]. 370 23